Skip to main content
Intermediate Technical IVT

partial response

Tumor response category indicating significant reduction in tumor burden but not complete disappearance.

Full Definition

Partial response (PR) is a standardized oncological endpoint defined as a decrease of at least 30% in the sum of longest diameters of target lesions, taking as reference the baseline sum longest diameters. This measurement must be confirmed by repeat assessments at least four weeks apart. Partial response represents meaningful clinical benefit and is often considered a successful treatment outcome in oncology trials. The designation requires that no new lesions appear and that existing non-target lesions do not progress unequivocally.

Usage

Usage note: Always specify measurement criteria used when reporting partial response in clinical documentation.

In Context

  • "The patient achieved a partial response after three cycles of immunotherapy." — Treatment response assessment
  • "Partial response rates were significantly higher in the experimental arm (42% vs 18%)." — Clinical trial results

Also known as

PR

Contrasted with

complete response progressive disease

Don't confuse with

stable disease minor response

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON